IP Verse

Azurity Pharmaceuticals competitive analysis

Latest PTAB cases involving Azurity Pharmaceuticals

Discover the latest PTAB cases involving Azurity Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Feb 3, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Azurity Pharmaceuticals

IPR2025-00945May 1, 2025AZURITY PHARMACEUTICALSHELSINN HEALTHCARETrial Instituted
IPR2025-00946May 1, 2025AZURITY PHARMACEUTICALSHELSINN HEALTHCARETrial Instituted
IPR2025-00947May 1, 2025AZURITY PHARMACEUTICALSHELSINN HEALTHCARETrial Instituted
IPR2025-00948May 1, 2025AZURITY PHARMACEUTICALSHELSINN HEALTHCARETrial Instituted
IPR2025-00949May 1, 2025AZURITY PHARMACEUTICALSHELSINN HEALTHCARETrial Instituted
PGR2025-00035Feb 28, 2025AZURITY PHARMACEUTICALSHERON THERAPEUTICSDiscretionary Denial
PGR2025-00036Feb 28, 2025AZURITY PHARMACEUTICALSHERON THERAPEUTICSDiscretionary Denial
IPR2025-00427Jan 9, 2025AZURITY PHARMACEUTICALSEXELIXISDiscretionary Denial
IPR2025-00210Nov 18, 2024AZURITY PHARMACEUTICALSEXELIXISInstitution Denied

Peer Comparison New

IP litigation analysis comparing Azurity Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jan 29, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
AZURITY PHARMACEUTICALS - - 9 -
EXELIXIS - 8 - 2
HELSINN HEALTHCARE - - - 12
HERON THERAPEUTICS - - - 2